image: These plant-based microbeads absorb and trap fat.
Credit: Yue Wu
WASHINGTON, Aug. 21, 2025 — Weight-loss interventions, including gastric bypass surgery and drugs that prevent dietary fat absorption, can be invasive or have negative side effects. Now, researchers have developed edible microbeads made from green tea polyphenols, vitamin E and seaweed that, when consumed, bind to fats in the gastrointestinal tract. Preliminary results from tests with rats fed high-fat diets show that this approach to weight loss may be safer and more accessible than surgery or pharmaceuticals.
Yue Wu, a graduate student at Sichuan University, will present her team’s results at the ACS Fall 2025 Digital Meeting, a meeting of the American Chemical Society.
“Losing weight can help some people prevent long-term health issues like diabetes and heart disease,” says Wu. “Our microbeads work directly in the gut to block fat absorption in a noninvasive and gentle way.”
Weight gain is caused by genetic and lifestyle factors, including eating a high-fat diet. A high-fat diet is defined by the U.S. Department of Agriculture as one where 35% or more of a person’s daily calories come from fat, as opposed to protein or carbohydrates. Some pharmaceuticals, such as orlistat, inhibit certain gastric enzymes from breaking down dietary fats, leading to less fat being absorbed by the body. Orlistat is a U.S. Food and Drug Administration (FDA)-approved medication and is effective for weight loss. However, for some people it causes serious side effects, including liver and kidney damage.
So, Wu and her colleagues wanted to target the fat absorption process with their weight-loss intervention but do so without negative side effects. “We want to develop something that works with how people normally eat and live,” says Wu.
To get started, the team created tiny plant-based beads that spontaneously form through a series of chemical bonds between the green tea polyphenols and vitamin E. These structures can form chemical tethers to fat droplets and serve as the fat-binding core of the microbeads. The researchers then coated the spheres in a natural polymer derived from seaweed to protect them from the acidic environment of the stomach. Once ingested, the protective polymer coating expands in response to the acidic pH, and the green tea polyphenols and vitamin E compounds bind to and trap partially digested fats in the intestine.
The microbeads are nearly flavorless, and the researchers foresee them being easily integrated into people’s diets. For example, the microbeads could be made into small tapioca- or boba-sized balls and added to desserts and bubble teas.
The researchers assessed the microbeads as a weight-loss treatment in rats. They put the animals into three groups (eight rats per group), those which were fed a high-fat diet (60% fats) either with or without microbeads and those which were fed a normal diet (10% fats) for 30 days. Rats fed the high-fat diet and microbeads:
- Lost 17% of their total body weight, while rats in the other groups didn’t lose weight.
- Had reduced adipose tissue and less liver damage compared to rats fed the high-fat and normal diets without microbeads.
- Excreted more fat in their feces compared to rats not given microbeads. The extra fat in the rats’ feces had no apparent ill effects on the animals’ health.
Additionally, the eight rats on high-fat diets that consumed microbeads showed similar intestinal fat excretion, but without the gastrointestinal side effects the researchers observed with a fourth group of rats they treated with orlistat.
Wu and her team have started working with a biotechnology company to manufacture the plant-based beads. “All the ingredients are food grade and FDA-approved, and their production can be easily scaled up,” says Yunxiang He, Sichuan University associate professor and co-author on Wu’s presentation.
They’ve also initiated a human clinical trial in collaboration with the West China Hospital of Sichuan University. “This represents a major step toward clinical translation of our polyphenol-based microbeads, following our foundational results,” says Wu. “We have officially enrolled 26 participants in our investigator-initiated trial, and we anticipate that preliminary data may become available within the next year.”
The research was funded by National Key R&D Program of China; the National Excellent Young Scientists Fund; the National Natural Science Foundation of China; the Talents Program of Sichuan Province; the Double First-Class University Plan of Sichuan University; the State Key Laboratory of Polymer Materials Engineering; the Tianfu Emei Program of Sichuan Province; the Postdoctoral Special Funding of Sichuan Province; the Postdoctoral Funding of Sichuan University; the Ministry of Education Key Laboratory of Leather Chemistry and Engineering; and the National Engineering Research Center of Clean Technology in Leather Industry.
A Headline Science YouTube Short about this topic will be posted on Thursday, Aug. 21. Reporters can access the video during the embargo period, and once the embargo is lifted the same URL will allow the public to access the content. Visit the ACS Fall 2025 program to learn more about this presentation, “Oral polyphenol-based microbeads with synergistic demulsification and fat locking for obesity treatment” and other science presentations.
###
The American Chemical Society (ACS) is a nonprofit organization founded in 1876 and chartered by the U.S. Congress. ACS is committed to improving all lives through the transforming power of chemistry. Its mission is to advance scientific knowledge, empower a global community and champion scientific integrity, and its vision is a world built on science. The Society is a global leader in promoting excellence in science education and providing access to chemistry-related information and research through its multiple research solutions, peer-reviewed journals, scientific conferences, e-books and weekly news periodical Chemical & Engineering News. ACS journals are among the most cited, most trusted and most read within the scientific literature; however, ACS itself does not conduct chemical research. As a leader in scientific information solutions, its CAS division partners with global innovators to accelerate breakthroughs by curating, connecting and analyzing the world’s scientific knowledge. ACS’ main offices are in Washington, D.C., and Columbus, Ohio.
To automatically receive press releases from the American Chemical Society, contact newsroom@acs.org.
Note to journalists: Please report that this research was presented at a meeting of the American Chemical Society. ACS does not conduct research, but publishes and publicizes peer-reviewed scientific studies.
Follow us: Facebook | LinkedIn | Instagram
Title
Oral polyphenol-based microbeads with synergistic demulsification and fat locking for obesity treatment
Abstract
Excessive fat intake is strongly linked to the growing prevalence of obesity and associated metabolic disorders. Orlistat is the only Food and Drug Administration-approved drug for limiting the absorption of fat; however, the unabsorbed fat in the colon can cause severe side effects. Here, we report a polyphenol-mediated fat-locking (PmFL) microbead made of green tea polyphenol, dietary fiber (alginate), and D-a-tocopherol that efficiently captures and excludes a broad spectrum of dietary fat derivatives in the gut. Mechanistically, PmFL microbeads actively capture emulsified fat droplets through gastrointestinal pH-responsive expansion and facilitate multiple molecular interaction-driven demulsification and fat locking. The high-fat dieted rats orally administered PmFL microbeads showed 17.02% weight loss, accompanied by reduced adipose tissue, alleviated liver damage, and lower blood fat levels. Notably, the rats exhibited direct excretion of fat-containing feces without side effects or blood glucose fluctuations. Our work provides a basis for novel dietary strategies to combat obesity.